Screener
LB Pharmaceuticals Inc LBRX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by LB Pharmaceuticals Inc in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The source filing: LB Pharmaceuticals Inc’s 10-Q, filed May 12, 2026.
- Filed
- May 12, 2026, 4:31 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-219607
| Line item | As of / March 31, 2026 | As of / December 31, 2025 |
|---|---|---|
| Commitments and contingencies (Note 12) | ||
| Stockholders’ equity | ||
| Common stock, $0.0001 par value, 500,000,000 shares authorized, 28,674,827 and 25,299,372 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively. | 3 | 3 |
| Additional paid-in capital | 527,064 | 430,667 |
| Accumulated deficit | (148,582) | (129,528) |
| Accumulated other comprehensive income | 208 | 168 |
| Total stockholders’ equity | 378,693 | $301,310 |
| Total liabilities and stockholders’ equity | $393,482 | $312,934 |
Item 1. Financial Statements
FAQ
- What is LB Pharmaceuticals Inc's total equity?
- LB Pharmaceuticals Inc (LBRX) reported total equity of $378.69M in Q1 2026.
- How has LB Pharmaceuticals Inc's total equity changed year-over-year?
- LB Pharmaceuticals Inc's total equity increased by 481.2% year-over-year, from -$99.34M to $378.69M.
- What is the long-term trend for LB Pharmaceuticals Inc's total equity?
- Over 2 years (2023 to 2025), LB Pharmaceuticals Inc's total equity has grown at a 195.6% compound annual growth rate (CAGR), from -$34.47M to $301.31M.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.
Ask your AI about LB Pharmaceuticals Inc's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude